Page last updated: 2024-11-02

pd 98059 and Hypophosphatemia, Familial

pd 98059 has been researched along with Hypophosphatemia, Familial in 1 studies

2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.

Hypophosphatemia, Familial: An inherited condition of abnormally low serum levels of PHOSPHATES (below 1 mg/liter) which can occur in a number of genetic diseases with defective reabsorption of inorganic phosphorus by the PROXIMAL RENAL TUBULES. This leads to phosphaturia, HYPOPHOSPHATEMIA, and disturbances of cellular and organ functions such as those in X-LINKED HYPOPHOSPHATEMIC RICKETS; OSTEOMALACIA; and FANCONI SYNDROME.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nguyen, TM1
Lieberherr, M1
Fritsch, J1
Guillozo, H1
Alvarez, ML1
Fitouri, Z1
Jehan, F1
Garabédian, M1

Other Studies

1 other study available for pd 98059 and Hypophosphatemia, Familial

ArticleYear
The rapid effects of 1,25-dihydroxyvitamin D3 require the vitamin D receptor and influence 24-hydroxylase activity: studies in human skin fibroblasts bearing vitamin D receptor mutations.
    The Journal of biological chemistry, 2004, Feb-27, Volume: 279, Issue:9

    Topics: Calcitriol; Calcium; Calcium Channel Blockers; Cells, Cultured; Child, Preschool; Cytochrome P-450 E

2004